Replies to post #106083 on Amarantus Bioscience Holdings Inc (AMBS)

[joboggi]

lwol, 34 normal subjects and 10 AD patients. Wow. That will go a long way to allowing AMBS to sell Lympro to researchers who want to discern AD from non ad dementia.

Its the stated intention that will be the role of Lympro. ( See the twitter conference and many other communications )